RLCAX
Price
$7.84
Change
+$0.12 (+1.55%)
Updated
Apr 11 closing price
Net Assets
159.08M
VIVAX
Price
$63.21
Change
+$0.94 (+1.51%)
Updated
Apr 11 closing price
Net Assets
190.51B
Ad is loading...

RLCAX vs VIVAX

Header iconRLCAX vs VIVAX Comparison
Open Charts RLCAX vs VIVAXBanner chart's image
Columbia Disciplined Value A
Price$7.84
Change+$0.12 (+1.55%)
VolumeN/A
Net Assets159.08M
Vanguard Value Index I
Price$63.21
Change+$0.94 (+1.51%)
VolumeN/A
Net Assets190.51B
RLCAX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLCAX vs. VIVAX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLCAX is a Buy and VIVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 191B vs. RLCAX (159M). VIVAX pays higher dividends than RLCAX: VIVAX (2.14) vs RLCAX (1.45). RLCAX was incepted earlier than VIVAX: RLCAX (17 years) vs VIVAX (32 years). RLCAX (1.21) is less costly to investors than VIVAX (0.17). RLCAX is a more actively managed with annual turnover of: 60.00 vs. VIVAX (10.00). RLCAX has a lower initial minimum investment than VIVAX: RLCAX (2000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 0.72 vs. RLCAX (-11.56). VIVAX return over 5 years is better than : 64.30 vs. RLCAX (9.47).
RLCAXVIVAXRLCAX / VIVAX
Total Expense Ratio1.030.17606%
Annual Report Gross Expense Ratio1.210.17712%
Fund Existence17 years32 years-
Gain YTD-8.205-5.712144%
Front Load6%N/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets159M191B0%
Annual Yield % from dividends1.452.1468%
Returns for 1 year-11.560.72-1,613%
Returns for 3 years-11.488.14-141%
Returns for 5 years9.4764.3015%
Returns for 10 years-12.1688.68-14%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYEL0.440.02
+5.69%
Lyell Immunopharma
CPRX22.050.60
+2.80%
Catalyst Pharmaceuticals
INNV2.820.06
+2.17%
InnovAge Holding Corp
UHAL61.040.18
+0.30%
U-Haul Holding Company
NLSP1.35N/A
-0.01%
Nls Pharmaceutics Ltd